An accomplished courtroom advocate and counselor to management teams and boards of directors, Robert helps life sciences companies of all sizes navigate business conflicts. His deep industry knowledge and experience, as well as his foundational industry education through a B.S.E. and M.S.E. in biomedical engineering, have enabled Robert to successfully guide numerous companies through all manner of patent, trade secret and commercial disputes.
Robert’s clients and engagements span the spectrum of large multinationals, including UCB, Loxo Oncology (an Eli Lilly company), Pfizer, Novo Nordisk, Google and Abiomed, through emerging and startup companies, such as AnaptysBio, Avalyn Pharma, Melinta Therapeutics, Passage Bio, and Sutro Biopharma.
Often called in long before litigation begins, Robert counsels clients on litigation threats surrounding product launches, generic or biosimilar challenges, failed collaborations, contractual breaches, and trade secret misappropriation.
Robert’s trial and courtroom experience involves technologies across the life sciences industry, including small molecules, biologics, gene therapy, medical devices and software, and across numerous district courts throughout the United States and before the Patent Trial and Appeal Board. Such litigations span “bet the company” actions against commercial rivals, Hatch-Waxman and BPCIA actions against generic/biosimilar challengers, and disputes with investors and licensing partners, among others.
Robert is also dedicated to pro bono service. He has negotiated IP licenses and research grants on behalf of an international research foundation and represented children seeking special education services.
Regularly recognized for his accomplishments, Robert has been repeatedly recognized for his patent litigation practice by The Legal 500 and Super Lawyers. He was also previously named one of the nation’s top five life sciences lawyers under 40 by Law360.
While earning his M.S.E., Robert’s research involved laboratory work focused on the role of mechanotransduction pathways in promoting bone healing and growth.